287 related articles for article (PubMed ID: 30340515)
41. Surgical management of endolymphatic sac tumor: classification, outcomes and strategy. A single institution's experience.
Wu N; Ma X; Shen W; Hou Z; Han W; Dai P; Zhao H; Huang D; Han D; Yang S
Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):69-76. PubMed ID: 35739425
[TBL] [Abstract][Full Text] [Related]
42. The Gruppo Otologico experience of endolymphatic sac tumor.
Husseini ST; Piccirillo E; Taibah A; Paties CT; Almutair T; Sanna M
Auris Nasus Larynx; 2013 Feb; 40(1):25-31. PubMed ID: 22326122
[TBL] [Abstract][Full Text] [Related]
43. Endolymphatic sac tumors.
Wick CC; Manzoor NF; Semaan MT; Megerian CA
Otolaryngol Clin North Am; 2015 Apr; 48(2):317-30. PubMed ID: 25650230
[TBL] [Abstract][Full Text] [Related]
44. Endolymphatic sac tumor: a case report and review of the literature.
Reijneveld J; Hanlo P; Groenewoud G; Jansen G; van Overbeeke K; Tulleken C
Surg Neurol; 1997 Oct; 48(4):368-73. PubMed ID: 9315135
[TBL] [Abstract][Full Text] [Related]
45. Should endolymphatic sac tumors be considered part of the von Hippel-Lindau complex? Pathology case report.
Tibbs RE; Bowles AP; Raila FA; Fratkin JD; Hutchins JB
Neurosurgery; 1997 Apr; 40(4):848-55; discussion 855. PubMed ID: 9092862
[TBL] [Abstract][Full Text] [Related]
46. Current Treatment of Endolymphatic Sac Tumor of the Temporal Bone.
Mendenhall WM; Suárez C; Skálová A; Strojan P; Triantafyllou A; Devaney KO; Williams MD; Rinaldo A; Ferlito A
Adv Ther; 2018 Jul; 35(7):887-898. PubMed ID: 29923043
[TBL] [Abstract][Full Text] [Related]
47. Endolymphatic sac tumours.
Richards PS; Clifton AG
J Laryngol Otol; 2003 Aug; 117(8):666-9. PubMed ID: 12956928
[TBL] [Abstract][Full Text] [Related]
48. Neurologic manifestations of von Hippel-Lindau disease.
Butman JA; Linehan WM; Lonser RR
JAMA; 2008 Sep; 300(11):1334-42. PubMed ID: 18799446
[TBL] [Abstract][Full Text] [Related]
49. Endolymphatic sac tumour in von Hippel-Lindau disease: management strategies.
Zanoletti E; Girasoli L; Borsetto D; Opocher G; Mazzoni A; Martini A
Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):423-429. PubMed ID: 29165437
[TBL] [Abstract][Full Text] [Related]
50. Endolymphatic sac tumours.
Luff DA; Simmons M; Malik T; Ramsden RT; Reid H
J Laryngol Otol; 2002 May; 116(5):398-401. PubMed ID: 12081005
[TBL] [Abstract][Full Text] [Related]
51. Endolymphatic sac papillary tumor: a case report.
Yu SJ; Chen YD; Gao F; Qiu XG; Chang H
Chin Med J (Engl); 2011 Nov; 124(22):3828-9. PubMed ID: 22340250
[TBL] [Abstract][Full Text] [Related]
52. [Endolymphatic sac tumor and von Hippel-Lindau disease. Review of the literature].
de Minteguiaga C; García Ibáñez L; Tran Ba Huy P
Acta Otorrinolaringol Esp; 2002; 53(7):515-20. PubMed ID: 12487074
[TBL] [Abstract][Full Text] [Related]
53. von Hippel-Lindau disease: surveillance strategy for endolymphatic sac tumors.
Poulsen ML; Gimsing S; Kosteljanetz M; Møller HU; Brandt CA; Thomsen C; Bisgaard ML
Genet Med; 2011 Dec; 13(12):1032-41. PubMed ID: 21912262
[TBL] [Abstract][Full Text] [Related]
54. Coexpression of erythropoietin and its receptor in endolymphatic sac tumors.
Vogel TW; Vortmeyer AO; Lubensky IA; Lee YS; Furuta M; Ikejiri B; Kim HJ; Lonser RR; Oldfield EH; Zhuang Z
J Neurosurg; 2005 Aug; 103(2):284-8. PubMed ID: 16175858
[TBL] [Abstract][Full Text] [Related]
55. Cochlear implantation for hearing loss associated with bilateral endolymphatic sac tumors in von Hippel-Lindau disease.
Jagannathan J; Lonser RR; Stanger RA; Butman JA; Vortmeyer AO; Zalewski CK; Brewer C; Surowicz C; Kim HJ
Otol Neurotol; 2007 Oct; 28(7):927-30. PubMed ID: 17468670
[TBL] [Abstract][Full Text] [Related]
56. Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease: implications for their natural history, diagnosis, and treatment.
Kim HJ; Butman JA; Brewer C; Zalewski C; Vortmeyer AO; Glenn G; Oldfield EH; Lonser RR
J Neurosurg; 2005 Mar; 102(3):503-12. PubMed ID: 15796386
[TBL] [Abstract][Full Text] [Related]
57. Isolate vertigo crisis revealing an endolymphatic sac tumor.
Codreanu C; Tran Ba Huy P
Rom J Morphol Embryol; 2010; 51(2):387-9. PubMed ID: 20495761
[TBL] [Abstract][Full Text] [Related]
58. [Expression of VHL, VEGF and HIF-1α in endolymphatic sac tumors].
Mao ML; Zhao YH; Ma DL; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1228-1233. PubMed ID: 34719159
[No Abstract] [Full Text] [Related]
59. Symptoms and clinical features in patients affected by endolymphatic sac tumor: a systematic review and meta-analysis.
Gioacchini FM; Kaleci S; Chiarella G; Viola P; Pisani D; Scarpa A; Tulli M; Pace A; Iannella G; Re M
Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5081-5088. PubMed ID: 35704074
[TBL] [Abstract][Full Text] [Related]
60. An endolymphatic sac tumor with imaging features of aneurysmal bone cysts: differential diagnostic considerations.
Alkonyi B; Günthner-Lengsfeld T; Rak K; Nowak J; Solymosi L; Hagen R
Childs Nerv Syst; 2014 Sep; 30(9):1583-8. PubMed ID: 24881035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
